This article has been updated from a previous version to reflect the updated name of the SARS-CoV-2 virus, which was previously named 2019-nCoV.
NEW YORK – Qiagen is developing a pair of molecular assays to detect SARS-CoV-2, the virus that causes COVID-19, from nasal swabs of symptomatic patients, a company executive said this week.